Interaction Between Sclerostin and Mast Cells in Fibro-Osseous Lesions of the Jaws
- PMID: 39740106
- DOI: 10.1111/odi.15232
Interaction Between Sclerostin and Mast Cells in Fibro-Osseous Lesions of the Jaws
Abstract
Objective: To assess the sclerostin, β-catenin, and tryptase expression in fibro-osseous lesions (FOL) of the jaws.
Subjects and methods: Immunohistochemistry analysis was performed for these proteins on FOL and non-lesional bone. The sclerostin-positive cells were scored from 0 (no expression) to 3 (high expression).
Results: We analyzed 46 FOL biopsies and selected 38 patients. Categorization showed 15 fibrous dysplasia (FD), eight juvenile trabecular ossifying fibroma (JTOF), two psammomatoid ossifying fibroma (PsOF), and 13 FOL. We found more sclerostin-positive cells in fibrous tissue than in bone, showing a phenotype like mast cells with strong dot-cytoplasmic positivity. The analysis of sclerostin-positive cell lesions (scored as 2 and 3) showed also tryptase positivity in 80.9% of 21 biopsies. β-catenin was diffusely expressed on the fibrous component, mostly with cytosol staining. Non-lesional bone showed sclerostin expression in medullary spaces and a few osteocytes.
Conclusions: Sclerostin-positive cells are mostly found in the fibrous tissue of FOL, and the tryptase mast cell marker was present in most of the lesions that were positive for sclerostin.
Keywords: SOST protein; bone diseases; bone fibrous dysplasia; developmental; human; mast cells; ossifying fibroma.
© 2024 John Wiley & Sons Ltd.
References
-
- Akers, I. A., M. Parsons, M. R. Hill, et al. 2000. “Mast Cell Tryptase Stimulates Human Lung Fibroblast Proliferation via Protease‐Activated Receptor‐2.” American Journal of Physiology. Lung Cellular and Molecular Physiology 278, no. 1: L193–L201.
-
- Bellido, T. 2014. “Osteocyte‐driven bone remodeling.” Calcified Tissue International 94: 25–34.
-
- Diolintzi, A., M. S. Pervin, and E. C. Hsiao. 2024. “Immunologic Aspects in Fibrodysplasia Ossificans Progressiva.” Biomolecules 14, no. 3: 357.
-
- Dreyer, T. J., J. A. Keen, L. M. Wells, and S. J. Roberts. 2023. “Novel Insights on the Effect of Sclerostin on Bone and Other Organs.” Journal of Endocrinology 257, no. 2: e220209.
-
- Fischer, V., and M. Haffner‐Luntzer. 2022. “Interaction Between Bone and Immune Cells: Implications for Postmenopausal Osteoporosis.” Seminars in Cell & Developmental Biology 123: 14–21.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
